Leonard S. Schleifer, CEO & President at REGENERON PHARMACEUTICALS INC (REGN), sold 7,900 shares at $67.50 ($522K) on 2011-09-06, disclosed to the SEC on 2011-09-08.
Scheduled sale ($522k) by CEO & President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $63.01 | 90 | $6K | 1.1% |
| 2 | $65.27 | 3,500 | $228K | 43.8% |
| 3 | $65.56 | 180 | $12K | 2.3% |
| 4 | $66.42 | 2,700 | $179K | 34.4% |
| 5 | $66.54 | 630 | $42K | 8.0% |
| 6 | $67.50 | 300 |
| $20K |
| 3.9% |
| 7 | $68.42 | 500 | $34K | 6.6% |
| Total | $66.03 avg | 7,900 | $522K | 100% |
| Filing → |
| REGN | SELL | 2024-05-17 | $44.7M | — | Filing → |
| REGN | SELL | 2024-05-15 | $70.1M | — | Filing → |
| REGN | SELL | 2022-04-07 | $10.1M | — | Filing → |